Posted on

Pfizer

VN:F [1.9.11_1134]
Rating: 0 (from 0 votes)
An expiring patent for the little blue pill is making Pfizer blue these days. Pfizer’s blockbuster Viagra will face competition from generics starting next year. To prepare, the company is scrambling to find other uses for the drug. It’s also making variations of Viagra, such as a chewable tablet called Viagra Jet, which it’s already selling in Mexico.Like many big pharmas facing a generics threat, Pfizer is slimming down and restructuring. It recently closed its major research facility in Sandwich, England, which employed 2,400 people. In March, Pfizer also announced a strategy to spin off four non-pharma units to focus on its core business. —S.D.

source

VN:F [1.9.11_1134]
Customer Service
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Environmental Impact
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Corporate Welfare / Subsidies
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Employee Treatment
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Safety / Health
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Criminal Activity
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Outsourcing
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Community
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Sponsorships
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Politics
Rating: 0.0/5 (0 votes cast)

About corporatOCRACY

Corporatism meets Democracy; Wall Street meets Main Street.

Leave a Reply

Your email address will not be published. Required fields are marked *


*